vimarsana.com
Home
Live Updates
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcrip
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcrip
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.
Related Keywords
Orlando ,
Florida ,
United States ,
Japan ,
Hawaii ,
America ,
Hawaiian ,
Annabel Samimy ,
Gena Wang ,
Danielle Brill ,
Lisa Walter ,
Vikram Purohit ,
Alec Stranahan ,
Brian Skorney ,
Raymond James ,
Patrick Christmas ,
Steve Pakola ,
Ellie Merle ,
Regenxbio Inc ,
Muscular Dystrophy Association Conference ,
Barclays ,
Exchange Commission ,
Morgan Stanley ,
Nasdaq ,
Call Transcript February ,
Chief Legal ,
Ken Mills ,
Chief Medical Officer ,
Vit Vasista ,
Chief Financial Officer ,
Hawaiian Eye ,
Rare Disease ,
Best Skin ,
Most Breweries Per ,
Luca Issi ,